INS and prostate carcinoma: In another in vitro study, insulin via the upregulation of Forkhead Box Protein C2 (FOXC2) promotes migration and invasion of prostate cancer cells and activation of insulin signaling pathway and inhibition of PI3K and MAPK pathways lead to epithelial-mesenchymal transition [44].